Therefore, the results presented here, employing a mouse model for genetic specific inactivation of AMPKα1 in hepatocytes, further extend the evidence for the liver as a key driver of immune and inflammatory responses during sepsis and strongly validate AMPK as a potential therapeutic target. This evidence concerns the gene PRKAA2 and Sepsis.